Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study.

ABSTRACT: Although coronary artery disease (CAD) and advanced liver fibrosis (AdLF) are commonly associated in patients with non-alcoholic fatty liver disease (NAFLD), the prevalence of AdLF and the diagnostic performance of non-invasive fibrosis tests (NITs) in CAD patients remains unknown. We aimed to prospectively screen for AdLF in patients with documented CAD using NITs and Fibroscan. High and intermediate zones of NITs were combined to define AdLF. AdLF was suspected whenever APRI ≥ 0.5, Forns index ≥ 4.2, NAFLD fibrosis score (NFS) ≥ -1.455/0.12 for age

SUBMITTER: Thevenot T 

PROVIDER: S-EPMC9135299 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature